| Ms Jennifer Lynn Diekmann, BSN | |
|
604 N Washington St, Council Grove, KS 66846-1422 | |
| (620) 767-5126 | |
| (620) 767-6910 |
| Full Name | Ms Jennifer Lynn Diekmann |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 604 N Washington St, Council Grove, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508998600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | 1493418051 (Kansas) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 93418 (Kansas) | Primary |
| Entity Name | Anesthesia Associates Of Central Kansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164494084 PECOS PAC ID: 6406744093 Enrollment ID: O20040121000483 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
| Entity Name | Excel Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366559130 PECOS PAC ID: 1850397787 Enrollment ID: O20061016000529 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
| Entity Name | Sweet Dreams Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508133497 PECOS PAC ID: 0042477705 Enrollment ID: O20191206000961 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
| Entity Name | Herington Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447829536 PECOS PAC ID: 8527469188 Enrollment ID: O20210713002964 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
| Entity Name | Sound Physicians Anesthesiology Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295356277 PECOS PAC ID: 1254751407 Enrollment ID: O20230119000417 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Lynn Diekmann, BSN 600 N Washington St, Council Grove, KS 66846-1499 Ph: (620) 767-6811 | Ms Jennifer Lynn Diekmann, BSN 604 N Washington St, Council Grove, KS 66846-1422 Ph: (620) 767-5126 |
News Archive
Health officials in Abu Dhabi announced at a forum that there is an exponential rise in the number of obese and overweight children in the country. The country is gearing up to tackle this problem to reduce the body mass index (BMI) of the children by at least 15 percent by the year 2020.
The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Reckitt Benckiser Group PLC today announces it has signed a definitive merger agreement with Schiff Nutrition International, Inc. a leading provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere. The Board of Directors of Schiff has approved the transaction and will recommend that its stockholders tender their shares into Reckitt Benckiser's previously announced cash tender offer of $42.00 per share, valuing Schiff at $1.4 billion.
› Verified 2 days ago
Peggy Ann Smith, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 North Washington, Council Grove, KS 66846 Phone: 620-767-6811 |